Regeneron Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Regeneron Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Regeneron Pharmaceuticals Inc Strategy Report
- Understand Regeneron Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Regeneron Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4059520A1 | Application | ANTIKÖRPER GEGEN ACTIVIN A UND ANWENDUNGEN DAVON | A61K2039/505; A61K2039/507; A61K39/395; A61K39/3955; A61P19/02; A61P19/10; A61P21/00; A61P21/02; A61P21/04; A61P21/06; A61P25/00; A61P25/16; A61P3/00; A61P3/04; A61P3/10; A61P35/00; A61P43/00; C07K16/22; C07K2317/31; C07K2317/33; C07K2317/76; C07K2317/92 | September 21, 2022 |
EP4059492A1 | Application | ZUSAMMENSETZUNGEN UND VERFAHREN ZUM HERSTELLEN VON PROTEINMIKROPARTIKELN | A61K38/17; A61K38/177; A61K38/179; A61K47/62; A61K9/16; A61K9/1611; A61K9/1617; A61K9/1623; A61K9/1658; A61K9/1694; A61K9/50; A61K9/5031; A61K9/5089; A61P27/02; A61P35/00; A61P9/10 | September 21, 2022 |
EP4059020A1 | Application | VERFAHREN UND SYSTEME ZUM IDENTIFIZIEREN, KLASSIFIZIEREN UND/ODER EINORDNEN GENETISCHER SEQUENZEN | C12Q1/6869; C12Q1/70; G16B10/00; G16B20/30; G16B30/10; G16B30/20; G16B45/00 | September 21, 2022 |
EP3720279B1 | Grant | MÄUSE MIT MANIPULIERTER IMMUNOGLOBULIN-LAMBDA-LEICHTKETTE UND VERWENDUNGEN DAVON | A01K2207/15; A01K2217/072; A01K2227/105; A01K2267/01; A01K67/0275; A01K67/0278; C07K16/00; C07K16/461; C07K16/462; C07K2317/10; C07K2317/14; C07K2317/21; C07K2317/24; C07K2317/515; C12N9/1264; A01K2217/052; A01K2217/15 | September 21, 2022 |
CN115066432A | Application | 使用耳畸蛋白双载体系统治疗感觉神经性听力损失的组合物和方法 | September 16, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer